European Pharmaceutical Manufacturer is a leading publication that covers the pharma/biopharma manufacturing supply chain from formulation to distribution, providing readers with the latest news, perspectives, developments, and breakthroughs in this high-tech industry. The bi-monthly magazine is distributed to over 18,000 readers, including leaders and key influencers in European pharmaceutical manufacturing.
Self-administration drug delivery devices must undergo required human factors (HF) studies before being launched to ensure any potential user risks are identified and minimized.
To learn more about the study, please read the full article on page 29.